Preoperative testing for immunotherapy-induced endocrinopathy in breast cancer: Real-world data, literature review, and suggested management protocol
Journal of Surgery and Medicine · 22.06.2026 · 10 (6) · e8398
DOI: 10.28982/josam.8398 ↗Kurz gefasst
Studienprotokoll in der Zeitschrift Journal of Surgery and Medicine, online erschienen am 22.06.2026. Verfasst von Gerard Mccabe und 2 weiteren Autor:innen. Die Arbeit nennt 20 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Background/Aim: Triple-negative breast cancer (TNBC) is an aggressive subtype for which pembrolizumab-based neoadjuvant therapy has demonstrated improved outcomes. However, immune checkpoint inhibitors, including pembrolizumab, are associated with endocrine toxicities such as hypothyroidism, hypophysitis, and adrenal insufficiency, which may significantly complicate perioperative care. This study aimed to evaluate real-world preoperative endocrine testing and propose a practical management protocol.
Methods
This retrospective study evaluated 28 patients with TNBC at Western General Hospital who received pembrolizumab before surgery between March 2023 and December 2024. Clinical data, endocrine function tests, surgical outcomes, and adverse events were analyzed.
Results
Endocrinopathies occurred in a subset of patients, including one case of hypothyroidism and two cases of adrenal insufficiency. Only 36% of patients underwent cortisol testing preoperatively.
Conclusion
We propose a protocol for routine preoperative endocrine screening in this population, including early-morning cortisol and thyroid function tests. Although the incidence is low, these complications may be severe, and implementing this protocol may reduce the risk of perioperative complications associated with immunotherapy-induced endocrinopathies.
Zitieren
APA
Mccabe, G., Turnbull, A., & Kulkarni, D. (2026). Preoperative testing for immunotherapy-induced endocrinopathy in breast cancer: Real-world data, literature review, and suggested management protocol. Journal of Surgery and Medicine, 10(6), e8398. https://doi.org/10.28982/josam.8398
Vancouver
Mccabe G, Turnbull A, Kulkarni D. Preoperative testing for immunotherapy-induced endocrinopathy in breast cancer: Real-world data, literature review, and suggested management protocol. Journal of Surgery and Medicine. 2026;10(6):e8398. doi:10.28982/josam.8398
BibTeX
@article{Mccabe2026,
author = {Mccabe, Gerard and Turnbull, Arran and Kulkarni, Dhananjay},
title = {Preoperative testing for immunotherapy-induced endocrinopathy in breast cancer: Real-world data, literature review, and suggested management protocol},
journal = {Journal of Surgery and Medicine},
year = {2026},
volume = {10},
number = {6},
pages = {e8398},
doi = {10.28982/josam.8398}
}
EUVIMED